XML 47 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional-paid in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning Balance at Dec. 31, 2020 $ 192,491 $ 34 $ 287,829 $ 27 $ (95,399)
Beginning Balance (in shares) at Dec. 31, 2020   33,964,000      
Stock-based compensation expense 21,750   21,750    
Purchase of common stock under Employee Stock Purchase Plan 60   60    
Purchase of common stock under Employee Stock Purchase Plan (in shares)   7,064      
Issuance of common stock, net 1,298 $ 1 1,297    
Issuance of common stock, net (in shares)   642,314      
Forfeiture of restricted stock (in shares)   (2,165)      
Other comprehensive loss (89)     (89)  
Net loss (84,686)       (84,686)
Ending Balance at Dec. 31, 2021 $ 130,824 $ 35 310,936 (62) (180,085)
Ending Balance (in shares) at Dec. 31, 2021 34,611,213 34,611,213      
Stock-based compensation expense $ 5,266   5,266    
Purchase of common stock under Employee Stock Purchase Plan 139   139    
Purchase of common stock under Employee Stock Purchase Plan (in shares)   31,832      
Issuance of common stock, net 61   61    
Issuance of common stock, net (in shares)   22,764      
Issuance of common stock pursuant to restricted stock units (Shares)   310,600      
Other comprehensive loss (234)     (234)  
Net loss (23,386)       (23,386)
Ending Balance at Mar. 31, 2022 112,670 $ 35 316,402 (296) (203,471)
Ending Balance (in shares) at Mar. 31, 2022   34,976,409      
Beginning Balance at Dec. 31, 2021 $ 130,824 $ 35 310,936 (62) (180,085)
Beginning Balance (in shares) at Dec. 31, 2021 34,611,213 34,611,213      
Stock-based compensation expense $ 19,831   19,831    
Purchase of common stock under Employee Stock Purchase Plan 196   196    
Purchase of common stock under Employee Stock Purchase Plan (in shares)   76,606      
Issuance of common stock, net 11   11    
Issuance of common stock, net (in shares)   10,047      
Issuance of common stock under equity offering (in shares)   12,767      
Issuance of common stock under equity offering 50   50    
Issuance of common stock pursuant to restricted stock units (Shares)   551,450      
Issuance Of Common Stock Pursuant To Restricted Stock Units (1)   (1)    
Other comprehensive loss (136)     (136)  
Net loss (81,580)       (81,580)
Ending Balance at Dec. 31, 2022 $ 69,195 $ 35 331,023 (198) (261,665)
Ending Balance (in shares) at Dec. 31, 2022 35,262,083 35,262,083      
Stock-based compensation expense $ 3,431   3,431    
Purchase of common stock under Employee Stock Purchase Plan 31   31    
Purchase of common stock under Employee Stock Purchase Plan (in shares)   24,754      
Issuance of common stock, net (in shares)   2,969      
Issuance of common stock pursuant to restricted stock units (Shares)   462,150      
Issuance Of Common Stock Pursuant To Restricted Stock Units 1 $ 1      
Other comprehensive loss 134     (134)  
Net loss (19,543)       (19,543)
Ending Balance at Mar. 31, 2023 $ 53,249 $ 36 $ 334,485 $ (64) $ (281,208)
Ending Balance (in shares) at Mar. 31, 2023 35,751,956 35,751,956